5 results for author:"Woodhead S.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (1)
| AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. Yap T.A., Walton M.I., Grimshaw K.M., Te Poele R.H., Eve P.D., Valenti M.R., de Haven Brandon A.K., Martins V., Zetterlund A., Heaton S.P. et al. Clin. Cancer Res. 18:3912-3923(2012) · Mapped (2) |
| Identification of inhibitors of protein kinase B using fragment-based lead discovery. Saxty G., Woodhead S.J., Berdini V., Davies T.G., Verdonk M.L., Wyatt P.G., Boyle R.G., Barford D., Downham R., Garrett M.D. et al. J. Med. Chem. 50:2293-2296(2007) · Mapped (4) |
| A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera. Davies T.G., Verdonk M.L., Graham B., Saalau-Bethell S., Hamlett C.C., McHardy T., Collins I., Garrett M.D., Workman P., Woodhead S.J. et al. J. Mol. Biol. 367:882-894(2007) · UniProtKB (1) · Mapped (3) |
| Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B. Collins I., Caldwell J., Fonseca T., Donald A., Bavetsias V., Hunter L.J., Garrett M.D., Rowlands M.G., Aherne G.W., Davies T.G. et al. Bioorg. Med. Chem. 14:1255-1273(2006) · Mapped (2) |
| Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation. Gill A.L., Frederickson M., Cleasby A., Woodhead S.J., Carr M.G., Woodhead A.J., Walker M.T., Congreve M.S., Devine L.A., Tisi D. et al. J. Med. Chem. 48:414-426(2005) · Mapped (1) |